You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Systematic review of pharmacologic and non-pharmacologic interventions to manage cognitive alterations after chemotherapy for breast cancer
|
|---|---|
| Published in |
European Journal of Cancer (1965), January 2015
|
| DOI | 10.1016/j.ejca.2014.12.017 |
| Pubmed ID | |
| Authors |
Raymond J. Chan, Alexandra L. McCarthy, Jackie Devenish, Karen A. Sullivan, Alexandre Chan |
| Abstract |
Cognitive alterations are reported in breast cancer patients receiving chemotherapy. This has adverse effects on patients' quality of life and function. This systematic review investigates the effectiveness of pharmacologic and non-pharmacologic interventions to manage cognitive alterations associated with breast cancer treatment. |
X Demographics
The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 2 | 25% |
| United States | 1 | 13% |
| India | 1 | 13% |
| El Salvador | 1 | 13% |
| Spain | 1 | 13% |
| Unknown | 2 | 25% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 4 | 50% |
| Practitioners (doctors, other healthcare professionals) | 3 | 38% |
| Scientists | 1 | 13% |
Mendeley readers
The data shown below were compiled from readership statistics for 302 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Canada | 2 | <1% |
| Germany | 1 | <1% |
| Indonesia | 1 | <1% |
| Portugal | 1 | <1% |
| United Kingdom | 1 | <1% |
| Brazil | 1 | <1% |
| Denmark | 1 | <1% |
| China | 1 | <1% |
| Unknown | 293 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 40 | 13% |
| Researcher | 39 | 13% |
| Student > Master | 36 | 12% |
| Student > Bachelor | 36 | 12% |
| Student > Doctoral Student | 29 | 10% |
| Other | 65 | 22% |
| Unknown | 57 | 19% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 64 | 21% |
| Psychology | 63 | 21% |
| Nursing and Health Professions | 36 | 12% |
| Unspecified | 16 | 5% |
| Neuroscience | 14 | 5% |
| Other | 42 | 14% |
| Unknown | 67 | 22% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 March 2015.
All research outputs
#8,373,072
of 25,658,541 outputs
Outputs from European Journal of Cancer (1965)
#2,820
of 6,916 outputs
Outputs of similar age
#106,832
of 360,848 outputs
Outputs of similar age from European Journal of Cancer (1965)
#30
of 61 outputs
Altmetric has tracked 25,658,541 research outputs across all sources so far. This one has received more attention than most of these and is in the 66th percentile.
So far Altmetric has tracked 6,916 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.3. This one has gotten more attention than average, scoring higher than 58% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 360,848 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.
We're also able to compare this research output to 61 others from the same source and published within six weeks on either side of this one. This one is in the 49th percentile – i.e., 49% of its contemporaries scored the same or lower than it.